Conjugated Linoleic Acid Reduces Hepatic Steatosis, Improves Liver Function, and Favorably Modifies Lipid Metabolism in Obese Insulin-resistant Rats

Overview

Journal Lipids

Specialty Biochemistry

Date 2007 Aug 21

PMID 17707984

Citations 9

Authors

Amy Noto

Peter Zahradka

Natalia Yurkova

Xueping Xie

Evan Nitschmann

Malcolm Ogborn

Carla G Taylor

Affiliations

Soon will be listed here.

Abstract

CLA has been shown to induce or suppress excess liver lipid accumulation in various animal models. Interestingly, the state of insulin resistance may be an important modulator of this effect. The objective of the current study was to determine how feeding a dietary CLA mixture would affect liver lipid accumulation in insulin-resistant/obese and lean rats in relation to liver function, lipidemia, liver TAG and phospholipid FA composition, and expression of hepatic markers of FA transport, oxidation, and synthesis. Six-week-old fa/fa and lean Zucker rats (n = 20/genotype) were fed either a 1.5% CLA mixture or a control diet for 8 wk. CLA supplementation reduced liver lipid concentration of fa/fa rats by 62% in concurrence with improved liver function (lower serum alanine aminotransferase and alkaline phosphatase) and favorable modification of the serum lipoprotein profile (reduced VLDL and LDL and elevated HDL) compared with controlfed fa/fa rats. The fa/fa genotype had two-thirds the amount of CLA (as % total FA) incorporated into liver TAG and phospholipids compared with the lean genotype. In both genotypes, CLA altered the hepatic FA profile (TAG greater than phospholipids) and these changes were explained by a desaturase enzyme index. Liver-FA-binding protein and acyl CoA oxidase, markers of FA transport and oxidation, respectively, were expressed at higher levels in CLA-fed fa/fa rats. In summary, these results illustrate a strong relationship between the state of insulin resistance and liver lipid metabolism and suggest that CLA acts to favorably modify lipid metabolism in fa/fa Zucker rats.

Citing Articles

Evaluating the effect of a mixture of two main conjugated linoleic acid isomers on hepatic steatosis in HepG2 cellular model.

Jalilian A, Golmohammadi T, Meshkani R, Koushki M, Eivazi N, Babaei Khorzoughi R Mol Biol Rep. 2021; 48(2):1359-1370.

PMID: 33580458 DOI: 10.1007/s11033-021-06203-5.

Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in Zucker Rats.

Hong L, Zahradka P, Cordero-Monroy L, Wright B, Taylor C Nutrients. 2019; 11(4).

PMID: 31022865 PMC: 6521162. DOI: 10.3390/nu11040917.

Pathway-based approach using hierarchical components of collapsed rare variants.

Lee S, Choi S, Kim Y, Kim B, Hwang H, Park T Bioinformatics. 2016; 32(17):i586-i594.

PMID: 27587678 PMC: 5013912. DOI: 10.1093/bioinformatics/btw425.

Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial.

Ebrahimi-Mameghani M, Jamali H, Mahdavi R, Kakaei F, Abedi R, Kabir-Mamdooh B Croat Med J. 2016; 57(4):331-42.

PMID: 27586548 PMC: 5048220. DOI: 10.3325/cmj.2016.57.331.

Individual CLA Isomers, c9t11 and t10c12, Prevent Excess Liver Glycogen Storage and Inhibit Lipogenic Genes Expression Induced by High-Fructose Diet in Rats.

Maslak E, Buczek E, Szumny A, Szczepnski W, Franczyk-Zarow M, Kopec A Biomed Res Int. 2015; 2015:535982.

PMID: 26090419 PMC: 4450214. DOI: 10.1155/2015/535982.

References

Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R . Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37(4):917-23. DOI: 10.1053/jhep.2003.50161. View

Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim H, Tange T, Okuyama H . Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 2000; 49(9):1534-42. DOI: 10.2337/diabetes.49.9.1534. View

Zafrani E . Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch. 2003; 444(1):3-12. DOI: 10.1007/s00428-003-0943-7. View

Moloney F, Yeow T, Mullen A, Nolan J, Roche H . Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004; 80(4):887-95. DOI: 10.1093/ajcn/80.4.887. View

Navarro V, Zabala A, Macarulla M, Fernandez-Quintela A, Rodriguez V, Simon E . Effects of conjugated linoleic acid on body fat accumulation and serum lipids in hamsters fed an atherogenic diet. J Physiol Biochem. 2004; 59(3):193-9. DOI: 10.1007/BF03179915. View

Miyazaki M, Dobrzyn A, Sampath H, Lee S, Man W, Chu K . Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J Biol Chem. 2004; 279(33):35017-24. DOI: 10.1074/jbc.M405327200. View

Nakanishi T, Oikawa D, Koutoku T, Hirakawa H, Kido Y, Tachibana T . Gamma-linolenic acid prevents conjugated linoleic acid-induced fatty liver in mice. Nutrition. 2004; 20(4):390-3. DOI: 10.1016/j.nut.2003.12.014. View

Rahman S, Huda M, Uddin M, Akhteruzzaman S . Short-term administration of conjugated linoleic acid reduces liver triglyceride concentration and phosphatidate phosphohydrolase activity in OLETF rats. J Biochem Mol Biol. 2002; 35(5):494-7. DOI: 10.5483/bmbrep.2002.35.5.494. View

Blom D, Byrnes P, Jones S, Marais A . Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia. J Lipid Res. 2003; 44(1):212-7. DOI: 10.1194/jlr.d200013-jlr200. View

10.

Youssef W, McCullough A . Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis. 2002; 13(1):17-30. View

11.

Degrace P, Demizieux L, Gresti J, Chardigny J, Sebedio J, Clouet P . Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10,cis-12-isomer of linoleic acid. J Nutr. 2004; 134(4):861-7. DOI: 10.1093/jn/134.4.861. View

12.

Oku H, Wongtangtintharn S, Iwasaki H, Toda T . Conjugated linoleic acid (CLA) inhibits fatty acid synthetase activity in vitro. Biosci Biotechnol Biochem. 2003; 67(7):1584-6. DOI: 10.1271/bbb.67.1584. View

13.

Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M . Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care. 2004; 27(7):1798-811. DOI: 10.2337/diacare.27.7.1798. View

14.

Liu R, Mizuta M, Kurose T, Matsukura S . Early events involved in the development of insulin resistance in Zucker fatty rat. Int J Obes Relat Metab Disord. 2002; 26(3):318-26. DOI: 10.1038/sj.ijo.0801924. View

15.

Koteish A, Diehl A . Animal models of steatosis. Semin Liver Dis. 2001; 21(1):89-104. DOI: 10.1055/s-2001-12932. View

16.

Moya-Camarena S, Vanden Heuvel J, Blanchard S, Leesnitzer L, Belury M . Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res. 1999; 40(8):1426-33. View

17.

Riserus U, Arner P, Brismar K, Vessby B . Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002; 25(9):1516-21. DOI: 10.2337/diacare.25.9.1516. View

18.

Riserus U, Vessby B, Arnlov J, Basu S . Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr. 2004; 80(2):279-83. DOI: 10.1093/ajcn/80.2.279. View

19.

Roche H, Noone E, Sewter C, Mc Bennett S, Savage D, Gibney M . Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha. Diabetes. 2002; 51(7):2037-44. DOI: 10.2337/diabetes.51.7.2037. View

20.

Belury M . Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr. 2002; 22:505-31. DOI: 10.1146/annurev.nutr.22.021302.121842. View